AVXL vs NVR · $247.4M cap vs P/E 15, rev $4.21B
Anavex Life Sciences Corp (AVXL) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
Anavex Life Sciences Corp (AVXL) is a biotechnology company listed on NASDAQ.
NVR Inc (NVR) is a residential construction company listed on NYSE.
AVXL does not have a complete income-statement cache yet.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
AVXL currently screens at market cap $247.4M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the AVXL and NVR stock pages for the full models.
Not investment advice.